Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence

  1. Nicola Alessio
  2. Tiziana Squillaro
  3. Giovanni Di Bernardo
  4. Giovanni Galano
  5. Roberto De Rosa
  6. Mariarosa AB Melone
  7. Gianfranco Peluso
  8. Umberto Galderisi  Is a corresponding author
  1. Luigi Vanvitelli Campania University, Italy
  2. ASL Napoli 1, Italy
  3. National Research Council (CNR), Italy

Abstract

Senescent cells secrete several molecules, collectively named senescence-associated secretory phenotype (SASP). In the SASP of cells that became senescent following several in vitro chemical and physical stress, we identified the IGFBP-4 protein that can be considered a general stress mediator. This factor appeared to play a key role in senescence-paracrine signaling. We provided evidences showing that genotoxic injury, such as low dose irradiation, may promote an IGFBP-4 release in bloodstream both in mice irradiated with 100 mGy X-ray and in human subjects that received Computer Tomography. Increased level of circulating IGFBP-4 may be responsible of pro-aging effect. We found a significant increase of senescent cells in the lungs, heart, and kidneys of mice that were intraperitoneally injected with IGFBP-4 twice a week for two months. We then analyzed how genotoxic stressors may promote the release of IGFBP-4 and the molecular pathways associated with the induction of senescence by this protein.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nicola Alessio

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  2. Tiziana Squillaro

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Giovanni Di Bernardo

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Giovanni Galano

    Centro P.S.I. Napoli Est - Barra, Naples, Italy, ASL Napoli 1, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Roberto De Rosa

    Centro P.S.I. Napoli Est - Barra, Naples, Italy, ASL Napoli 1, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Mariarosa AB Melone

    Medical, Surgical, Neurological, Metabolic Sciences, and Aging, Luigi Vanvitelli Campania University, Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Gianfranco Peluso

    Institute of Agri-Environmental Biology and Forestry (IBAF), National Research Council (CNR), Napoli, Italy
    Competing interests
    The authors declare that no competing interests exist.
  8. Umberto Galderisi

    Experimental Medicine, Luigi Vanvitelli Campania University, Napoli, Italy
    For correspondence
    umberto.galderisi@unicampania.it
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0909-7403

Funding

Regione Campania (CUP B23D18000250007)

  • Umberto Galderisi

Regione Campania (CUP B23D18000250007)

  • Gianfranco Peluso

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The animals were handled in compliance with the protocols that were approved by the Animal Care and Use Committee of Luigi Vanvitelli Campania University. Italian Ministry of Health ethical approval n. 67/2012 A

Human subjects: Bone marrow aspirate samples were obtained from healthy donors (age 10-18 years) after informed consent. Campania Region Ethical Committee approval n. 317/2016 PR

Copyright

© 2020, Alessio et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,482
    views
  • 183
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicola Alessio
  2. Tiziana Squillaro
  3. Giovanni Di Bernardo
  4. Giovanni Galano
  5. Roberto De Rosa
  6. Mariarosa AB Melone
  7. Gianfranco Peluso
  8. Umberto Galderisi
(2020)
Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence
eLife 9:e54523.
https://doi.org/10.7554/eLife.54523

Share this article

https://doi.org/10.7554/eLife.54523

Further reading

    1. Stem Cells and Regenerative Medicine
    Sujeethkumar Prithiviraj, Alejandro Garcia Garcia ... Paul E Bourgine
    Research Article

    Tissue engineering strategies predominantly rely on the production of living substitutes, whereby implanted cells actively participate in the regenerative process. Beyond cost and delayed graft availability, the patient-specific performance of engineered tissues poses serious concerns on their clinical translation ability. A more exciting paradigm consists in exploiting cell-laid, engineered extracellular matrices (eECMs), which can be used as off-the-shelf materials. Here, the regenerative capacity solely relies on the preservation of the eECM structure and embedded signals to instruct an endogenous repair. We recently described the possibility to exploit custom human stem cell lines for eECM manufacturing. In addition to the conferred standardization, the availability of such cell lines opened avenues for the design of tailored eECMs by applying dedicated genetic tools. In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the composition and function of eECMs. Human mesenchymal stromal/stem cell (hMSC) lines were modified to knock out vascular endothelial growth factor (VEGF) and Runt-related transcription factor 2 (RUNX2) and assessed for their capacity to generate osteoinductive cartilage matrices. We report the successful editing of hMSCs, subsequently leading to targeted VEGF and RUNX2-knockout cartilage eECMs. Despite the absence of VEGF, eECMs retained full capacity to instruct ectopic endochondral ossification. Conversely, RUNX2-edited eECMs exhibited impaired hypertrophy, reduced ectopic ossification, and superior cartilage repair in a rat osteochondral defect. In summary, our approach can be harnessed to identify the necessary eECM factors driving endogenous repair. Our work paves the road toward the compositional eECMs editing and their exploitation in broad regenerative contexts.